Astrocyte Biomarkers in Alzheimer Disease
121 Citations•2021•
Bruna Bellaver, João Pedro Ferrari‐Souza, Lucas Uglione Da Ros
It is demonstrated that astrocyte biomarkers are consistently altered in AD and supports further investigation for their inclusion in the AD clinical research framework for observational and interventional studies.
Abstract
Despite significant progress, applications of astrocyte biomarkers in AD remain in their early days. This meta-analysis demonstrated that astrocyte biomarkers are consistently altered in AD and supports further investigation for their inclusion in the AD clinical research framework for observational and interventional studies.